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SUMMARY: Which theraphy to prevent post-thyroidectomy hypo-
calcemia?
D. PISANIELLO, D. PARMEGGIANI, A. PIATTO, N. AVENIA, 
M. d’AJELLO, M. MONACELLI, A. SANGUINETTI, 
U. PARMEGGIANI, P. SPERLONGANO
Hypocalcemia is one of the most frequent complications after total extra-
capsular thyroidectomy (TET). In most of cases it is a transient phenomenon.
The aim of this study is to evaluate if and how the oral administration of cal-
cium or calcium combined with D-vitamin could effectively prevent post-thyroi-
dectomy  hypocalcemia. 
A randomized prospective study was performed, recruiting 120 patients
who underwent total thyroidectomy.The patients in our series were randomly
assigned to one of two groups: group A - patients who received calcium lacto-
gluconate/ calcium carbonate (mg 300 per day); group B - patients who recei-
ved calcium carbonate/cholecalciferol therapy (calcium carbonate: 1500 mg
per day; cholecalciferol 400 UI per day). The groups were well mateched for
age, sex and pathologies. Patients of both A and B groups were divided in
two subgroups: those operated on for benign thyroid diseases (A1 and B1)
and those operated on for malignancy (A2, B2). 
Serum calcium assays, performed 24, 48 and 72 hours after surgery,
showed mean values of calcemia higher in patients of the B1 and B2 group.
Statistical analysis was performed using a Student's t test. Mean serum cal-
cium concentrations on post-operative day one, two and three were higher in
patients of the group B (p<<0.01). 
Early and combined oral administration of both calcium and vitamin D
seemed to prove major efficacy in preventing and treating post-operative hypo-
calcemia, showing mean serum calcium levels higher than those of patients
who received only oral calcium administration. Nevertheless, further studies
are necessary to validate these data.
RIASSUNTO: Quale terapia nella prevenzione dell’ipocalcemia post-
tiroidectomia totale?
D. PISANIELLO, D. PARMEGGIANI, A. PIATTO, N. AVENIA, 
M. d’AJELLO, M. MONACELLI, A. SANGUINETTI, 
U. PARMEGGIANI, P. SPERLONGANO
L'ipocalcemia è una delle più frequenti complicanze dopo tiroidectomia
totale. Scopo di questo studio è di valutare  se  e in che modo la somministra-
zione orale  di calcio  con  vitamina D  può  prevenire  l'ipocalcemia post-
tiroidectomia. 
È stato  condotto  uno  studio  prospettico  randomizzato, reclutando
120  pazienti  sottoposti  a tiroidectomia totale. I  pazienti  studiati  sono
stati randomizzati  in  uno  dei seguenti gruppi: gruppo  A - pazienti a cui è
stato somministrato ca  gluconato / calcio carbonato  (300 mg /die ); gruppo
B - pazienti a cui è stato somministrato calcio  carbonato/colecalciferolo (cal-
cio carbonato 1500 mg/die; colecalciferolo 400  UI / die). I  gruppi erano
omogenei per  età, sesso  e patologie. I pazienti  di  entrambi i gruppi  sono
stati  divisi in due  sottogruppi: quelli operati per tireopatie  benigne (A1 e
B1) e  quelli  operati  per cancro  (A2  e B2).  
I dosaggi  del  calcio  sierico  praticati  a 24, 48  e  72  ore  dall'inter-
vento  hanno  mostrato  valori  medi  della calcemia più  alti  nei  pazienti
dei  gruppi  B1 e B2. L'analisi  statistica  è stata condotta utilizzando il
test  di Student. La calcemia  in I, II e  III  giornata postoperatoria si  è
rivelata  più  alta  nei pazienti  del  gruppo B ( p < 0,01). 
La  somministrazione  precoce e combinata  di  calcio  e vitamina D  è
risultata  più  efficace  nella  prevenzione e nel trattamento  dell'ipocalcemia
post-operatoria, dal momento che  i valori medi di calcemia sono risultati più
alti  di  quelli dei  pazienti  a cui era stato somministrato soltanto calcio.
Ulteriori studi  sono  comunque  indispensabili  per  convalidare  questi
risultati.
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plications after total extracapsular thyroidectomy
(TET). It can occurr from two to five days after sur-
gery and requires post-operative supplementataion of
calcium to prevent and treat symptoms. In most of
cases it is a transient hypocalcemia whose incidence
varies from 2 to 53% in literature (1-18), while per-
manent hypocalcemia (requiring calcium replacement
therapy after one year) accounts for about 0,4-13,8%
(19). 
The aim of this study is to evaluate if and how the
Introduction
Hypocalcemia is one of the most frequent com-
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oral administration of calcium or calcium combined
with D-vitamin could effectively prevent post-thyroi-
dectomy  hypocalcemia.
Patients and methods
A randomized prospective study was performed from October
2003 up to April 2005, recruiting 120 patients who underwent total
thyroidectomy in order to determine the incidence of post-operati-
ve hypocalcemia. The principal exclusion criteria were hypercalce-
mia and chronic kidney failure.
On the basis of the oral calcium  therapy administrated, the
patients in our series were randomly assigned to one of two grou-
ps:
- group A - patients who received calcium  lactogluconate/cal-
cium carbonate (mg 300 per day );
- group B - patients who received calcium carbonate /cholecalci-
ferol therapy (calcium carbonate: 1500 mg per day; colecalcife-
rol 400 UI per day).
The two groups were well-matched for number, age, sex of
patients. Group A included 60 patients (28 males, 32 females;
mean age: 36,8 years old), all but 7 suffered from benign thyroid
disease; 7 patients suffered from thyroid malignancies (except C
cells tumours). Group B also included 60 patients (25 males and
35 females, mean age: 47,8 years old); also in this group 7 patients
were operated on for thyroid malignancies, all the others for beni-
gn thyroid pathologies. All the patients were euthyroid at the time
of surgery. Those who were hyperthyroid before, received the-
rapy until normalization of serum thyroid hormones.
All the patients started the therapy on the first post-operative
day combining L-tiroxin (100 γ os per day). Serum calcium levels
were measured 24, 48 e 72 hours after surgery. PTH was not
measured. Symptoms as perioral tingling, muscle cramp,
Chvostek’s and Trousseau's signs were also checked and registered
by nurses. If severe (defined as calcium concentrations of < 8
mg/dL) or symptomatic hypocalcemia occurred, patients received
iv calcium gluconate administration (18,4 mEq). Patients were
discharged in a mean of three days after surgery (if no complica-
tions occurred), and discontinued the oral therapy within 15 days
after the operation.
Serum calcium was checked 30, 60, 90 and 120 days after sur-
gery. If symptoms or signs of hypocalcemia lasted, the therapy
was continued until stable  normalization of serum calcium.
Data of the 4 groups were analyzed and compared. Statistical
analysis was performed using a Student's t test. In all cases α was
set on 0.01. 
Results
Patients of both A and B groups were divided in
two subgroups: those operated on for benign thyroid
diseases (A1 and B1) and those operated on for mali-
gnancy (A2 and B2). Serum calcium assays, perfor-
med 24, 48 and 72 hours after surgery, showed mean
values of calcemia of 8,4, 8,7 and 8,6 mg/dL (group
A1); 9,1, 9,3 and 9,3 mg/dL (group B1); 8,3, 8,2 and
8,4 mg/dL (group A2); 9, 8,7 and 9,4 mg/dL (group
B2). The SD were similar in all groups.
Mean serum calcium concentrations on post-ope-
rative day one, two and three were higher in patients
of the group B (p<0.01), furthermore ANOVA mea-
sures showed that the patients of the group B1 and
B2 had higher mean serum calcium concentrations
on post-operative day one, two and three (p<0.01)
(Figs. 1 and 2). A different trend in the post-operative
serum calcium was also observed in patients of the B1
and B2 groups, that is, those who underwent surgery
for malignancies of the thyroid, as discussed beyond
(Fig. 2). 
Four patients (6,6%) among the A group and 1 of
the group B (1,6%) experienced symptomatic hypo-
calcemia, which required intravenous administration
of  calcium gluconate (18,4 mEq iv). The patients
lamented muscle cramps and tingling. The only
adverse effect recorded among patients of the B
group was mild gastric pirosis, mostly in long-lasting
therapies.
Discussion
Hypocalcemia (defined as serum calcium < 8.0
mg/dL) is a common event after extensive thyroid
surgery. Some Authors in literature report an inciden-
ce of about 75% (20) of such complication. In most
of cases it is a transient phenomenon, not caused by
permanent hypoparathyroidism, but due to transient
parathyroid “stupor” (2, 3, 5-7, 10, 11, 13, 14, 19, 20).
Several hypotheses have been enunciated to
explain the phenomenon (1-3, 6-8, 10-14, 19, 20, 22),
whose incidence - it has to be stressed - is higher in
patients who undergo TET (12). Among the others,
unintentional ablation of parathyroids, or their ische-
mic damage - either as temporary ischemia (8, 17, 20),
either as the effect of bilateral truncal ligation of the
inferior thyroid artery or parathyroid artery (hypothe-
sis rejected by some Authors 9) - and hypoalbumine-
mia (6, 8, 20) resulting from surgical stress and hemo-
dilution (10) must be cited. A temporary parathyroid
insufficiency and the avidity of the skeleton for cal-
cium in hyperthyroid patients may also aggravate the
hypocalcemia (10, 21). 
Thus, the pathogenesis of early hypocalcemia is
multifactorial and yet unknown. As previously men-
tioned, hypoparathyroidism due to the incidental
resection of parathyroid glands is an exceptional
event (3), since it would be caused by the simulta-
neous resection of the four parathyroid glands and
would show permanent features. The incidence of
permanent hypocalcemia (about 6% in the Authors’
personal experience and from 0,4 to 13% in literatu-
re) (2-5, 8, 10, 12, 15, 20, 22) is low, so as the rare
event of the simultaneous resection of the four
parathyroids  - either for the surgeon's intraoperative
ability of recognition and his/her technical skill (15),
either for the frequent abnormalities of number and
site of the glands . 
Some of the Authors (3) showed in a previous
D. Pisaniello e Coll.
358
report that the incidence of post-operative hypocalce-
mia was higher in patients with mediastinal immer-
sion of the goiter (15%) in patients suffering from
autoimmune diseases (33%) and cancer (5%).
Hypocalcemia also seemed to be long-lasting or per-
manent in case of hyperfunction (6,25%) and recur-
rence (6,25%)(3). Some Authors in literature showed
a trend of hypoparathyroidism to be more frequent in
patients operated on for Graves' disease and thyroid
cancer than in other thyroid disorders (4,11).
Untreated hyperthyroidism, could be responsible for
a higher need for calcium afer surgery, because of the
increased bone reconstruction (the so-called “hungry
bone syndrome”). This is a complication to be afraid
of in cases of severe, prolonged hypertyroidism (21).
All the patients in our series were euthyroid at the
time of surgery (previous treatment in case of hyper-
functioning thyroid disease).
Others (12, 14,17) observed an increased inciden-
ce of permanent hypocalcemia in patients who
underwent total thyroidectomy, repeat thyroidectomy,
thyroidectomy plus neck dissection, whereas lobec-
tomy or subtotal thyroidectomy for benign euthyroid
disease were low risk operations.
In our Department the post-operative standard
therapy also provides early administration (since the
first post-operative day ) of L-tiroxin (100 γ/die os)
since, has reported elsewhere (3), we are firmly per-
suaded that the thyroid hormones deficiency is one of
the factors causing hypocalcemia and, thus, it should
be prevented.
Seldom patients present clear symptoms of hypo-
calcemia, such as tingling sensation, muscle cramps,
laryngeal spasm (at times lethal) and the typical
Chvostek's and Trousseau's signs. More frequently
patients experience peripheral tingling and perioral
numbness. Also anxiety and/or depression can
occurr, mostly in long-lasting hypocalcemia. Lastly, in
some cases, hypocalcemia can be just an asymptoma-
tic laboratory finding (17).
Usually the lowest serum calcium level is seen 48-
72 hours after surgery and returns to normal in seven
days after surgery (5). Symptoms usually occurr 24 to
48 hours after the operation (22). Some Authors (5)
showed that the critical period for monitoring of
serum calcium was 24 to 96 hours after surgery; and
if serum calcium replacement was not needed in the
first 72 hours after surgery, it would not seldom be
needed thereafter (5). That is why in our series serum
calcium was monitored  24, 48 and 72 hours after
surgery. We did not measure  serum  PTH since we
did not consider hypoparathyroidism to be the only
factor causing hypocalcemia.
In all the cases, we started the early administration
of L-tiroxin, calcium and D-vitamin (first post opera-
tive day), getting not only the calcium benefit, but
also the one of D-vitamin which plays a key role in
the absorbtion and the excretion of calcium (23); it
also seems to act directly on cellular membranes cau-
sing the sudden increase of intracellular calcium,
thanks to little variations of the cellular membrane.
Calcium carbonate is absorbed by the duodenum and
20 to 30% of such mechanism is a D-vitamin depen-
dent transfer (23). Low-phosphate diet should also be
recommended.
The patients of the B Group (calcium + vitamin
D administration) in our series showed (respectively
Which therapy to prevent post-thyroidectomy hypocalcemia?
359
Fig. 1 - Serum calcemia in pts. operated on for benign thyroid diseases. Fig. 2- Serum calcemia in pts. operated on for malignant thyroid diseases.
on first, second and third postoperative day) mean
calcium values of 0,7 0,6 and 0,7 mg/dL higher than
patients of the A group (only calcium administration).
This was a statistically significant difference
(p<0.001).
As shown in Figure 1, serum calcium shows an
increase on the second post-operative day and then a
slight decrease on the third post-operative day in
patients operated on for benign diseases. A clear
explanation of this calcium trend is yet not clear, but
is already reported by other Authors in literature
(13). Patients of the B group also showed fewer
symptoms than patients in the A group (respectively
1,6% vs. 6,6%).
It is also interesting to note that the multivariate
analysis of data concerning TET for malignancies
showed a different trend in calcium behaviour: in
these cases, in fact, patients of both A and B group
experienced a decrease of mean calcium values on the
second post-operative (p.o.) day, that increased on the
third p.o. day but showed mean values lower than
those of patients of both groups operated on for beni-
gn diseases (Fig. 2). This trend could be due to the
wider excisions performed in case of malignancy with
subsequent major parathyroid (transient or perma-
nent) damage.
The only argument in contrast with combined vita-
min D-calcium therapy (that is that both they could
inhibit PTH secretion by normally functioning
parathyroid glands) has been refuted by some Authors
in literature. (23). In addition, others (19) stated that
delayed serum calcium and phosphorus levels, measu-
red one week after starting calcium therapy, could pre-
view the outcome of hypocalcemia after thyroidec-
tomy, but the administration of any vitamin D analogs
would interfere with such predictability.
The only adverse effect recorded in patients of the
B group was gastric pirosis.It could be related to the
the sorbitol in the clinical formula. No signs or symp-
toms of vitamin D intoxication were observed.
Conclusions
Post-thyroidectomy (and, more extensively, post-
operative) hypocalcemia is a frequent and multifacto-
rial event (1-23). In most of cases it is a transient phe-
nomenon. In our experience it seems to reach the
lowest values in patients who undergo TET for mali-
gnant diseases, especially on the second post-operative
day.
Furthermore, early and combined oral administra-
tion of both calcium and vitamin D seemed to prove
major efficacy in preventing and treating post-operati-
ve hypocalcemia, showing mean serum calcium levels
higher than those of patients who received only oral
calcium administration.
Thus, further studies are necessary to validate these
data, and the review of data in literature suggest new
perspectives of investigation concerning the evaluation
of the efficacy of the oral administraton of combined
calcium and vitamin D starting from the day before
surgery in order to prevent post-thyroidectomy hypo-
calcemia, so as the use of thiazid diuretics to avoid
hypercalciuria (18).
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